Status:
COMPLETED
Anti-Inflammatory and Anti-Coagulant Effects of Salmon Polar Lipids
Lead Sponsor:
University of Limerick
Conditions:
Platelet Thrombus
Eligibility:
All Genders
Phase:
NA
Brief Summary
Inflammation is a normal immune response to tissue healing. However, uncontrolled and unresolved inflammation can initiate and further induce several chronic manifestations that contribute to chronic ...
Detailed Description
The present study investigates the putative anti-platelet effects in healthy human subjects (N=20) following ingestion of a novel supplement containing food-grade extracts of bio-active salmon polar l...
Eligibility Criteria
Inclusion
- The selection criteria of the subjects will be as follows:
- they need to be off medication and off intake of dietary supplements
- they need to have no blood clotting disorders or dyslipidaemia and
Exclusion
- Subjects with clotting disorders, dyslipidemia or being on medication (i.e. statins) or other supplements during the study will be excluded.
Key Trial Info
Start Date :
April 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 15 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03866265
Start Date
April 1 2019
End Date
December 15 2019
Last Update
December 19 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Limerick
Limerick, Co. Limerick, Ireland, V94 T9PX